| 摘要 |
The present invention provides therapeutically effective amounts of 6MNA prodrugs. The pharmaceutical composition comprises wherein R is H or COR', wherein R' is selected from the group consisting of C1 to C6 alkyl, (CH2)mO(CH2)n, (CH2)m(OC2H4)pO(CH2)n, (CH2)m(OC2H4)p, (OCH2H4)pONO2 and (OCH2H4)pO(CH2)n wherein m is an integer from 2 to 4, and n and p are integers from 1 to 4. Alternatively, R is a therapeutic moiety. |
